Skip to the card

2026-11-18 issue

Observed arrival · 2026-11-18

Beyond the Biobucks

beyondthebiobucks.com Visit website
Editorial interest 78/100 Selection signal · not a rating of the site

A research series and data terminal tracking what happened after major Chinese pharmaceutical licensing deals were signed.

Landing page captured for the 2026-11-18 issue.
For
Readers tracking China–West pharmaceutical licensing deals
Worth noticing
Its dashboard reports 50 tracked deals and explicitly cautions that the comparisons are a small sample, not a statistical test.

Field notes

The terminal lets readers filter deals by therapeutic area, modality, status, and signing year, then inspect an asset’s stage and timeline since signing. It reports 50 tracked deals and labels 12 ended or cut back; its own note says the sample is small and has not been statistically tested. A rewind control compares the chart with information public on an earlier date, while leaving the deal reading current.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Before Paste Became a Command

370,543 arrived 1,000 judged 990 catalogued Enter the complete issue
beyondthebiobucks.com

Landing page observed 2026-11-18. The live site may have changed.